KNSA Kiniksa Pharmaceuticals International

• None no insider bought on the open market
• $299K sold by 1 insider outside a trading plan
• $47.5M sold by 7 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Michael R Megna Chief Accounting Officer
   Planned sale
   $369K 4,600 shares at $80.30 14% of stake
   Traded Sep 3 Filed Sep 3
   ↗
3. G Bradley Cole Director
   Sale
   $299K 3,673 shares at $81.43 24% of stake
   Traded Jul 29 Filed Jul 31
   ↗
4. John F. Paolini Chief Medical Officer
   Planned sale
   $3.1M 58,424 shares at $53.71 47% of stake
   Traded May 1 Filed May 5
   ↗
5. Sanj K Patel CEO
   Planned sale
   $2.6M 48,565 shares at $54.02 100% of stake
   Traded May 1 Filed May 1
   ↗
6. Sanj K Patel CEO
   Planned sale
   $26.4M 508,339 shares at $51.96 100% of stake
   Traded Apr 28–30 Filed Apr 30
   ↗
7. Barry D Quart Director
   Planned sale
   $656K 13,099 shares at $50.10 51% of stake
   Traded Apr 28 Filed Apr 29
   ↗
8. Ross Moat COO
   Planned sale
   $80K 1,703 shares at $46.69 12% of stake
   Traded Apr 9 Filed Apr 13
   ↗
9. Michael R Megna Chief Accounting Officer
   Planned sale
   $309K 6,625 shares at $46.69 20% of stake
   Traded Apr 9 Filed Apr 13
   ↗
10. Ross Moat COO
    Planned sale
    $115K 2,367 shares at $48.58 16% of stake
    Traded Apr 6 Filed Apr 8
    ↗
11. Sanj K Patel CEO
    Planned sale
    $364K 7,278 shares at $50.01 100% of stake
    Traded Apr 6 Filed Apr 8
    ↗
12. Barry D Quart Director
    Planned sale
    $345K 6,901 shares at $50.00 36% of stake
    Traded Apr 6 Filed Apr 8
    ↗
13. Mark Ragosa CFO
    Planned sale
    $1.7M 36,722 shares at $45.92 75% of stake
    Traded Mar 9 Filed Mar 11
    ↗
14. John F. Paolini Chief Medical Officer
    Planned sale
    $1.8M 40,000 shares at $44.82 40% of stake
    Traded Mar 2 Filed Mar 4
    ↗
15. Barry D Quart Director
    Planned sale
    $126K 2,800 shares at $45.00 18% of stake
    Traded Feb 10–12 Filed Feb 12
    ↗
16. Mark Ragosa CFO
    Planned sale
    $772K 17,845 shares at $43.28 60% of stake
    Traded Feb 9 Filed Feb 11
    ↗

Also filed in the last 12 months, not counted as buying or selling: 76 option exercises, 18 share withholdings for taxes, 6 stock grants, 6 gifts, and 1 conversion.